Novel Microdevices, Inc
Novel Microdevices, Inc., based in Baltimore, MD, is at the forefront of medical diagnostic innovation, specializing in rapid point-of-care testing technologies. Recently awarded a substantial grant from the Maryland Department of Commerce, the company is establishing a GMP-compliant pilot manufacturing facility to produce groundbreaking microfluidic cartridges for its sample-to-answer diagnostic platform.
The company's flagship Novel Dx device employs advanced polymerase chain reaction (PCR) techniques to deliver lab-quality results for infectious diseases, including Flu, RSV, and COVID-19, in just 15 minutes. With its portable and battery-powered design, Novel Microdevices aims to enhance healthcare accessibility in low-resource settings and improve patient outcomes through timely diagnosis and treatment.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.